MX354047B - Cepas/celulas de lactobacillus secadas por aspersion, y el uso de las mismas contra helicobacter pylori. - Google Patents

Cepas/celulas de lactobacillus secadas por aspersion, y el uso de las mismas contra helicobacter pylori.

Info

Publication number
MX354047B
MX354047B MX2013014340A MX2013014340A MX354047B MX 354047 B MX354047 B MX 354047B MX 2013014340 A MX2013014340 A MX 2013014340A MX 2013014340 A MX2013014340 A MX 2013014340A MX 354047 B MX354047 B MX 354047B
Authority
MX
Mexico
Prior art keywords
lactobacillus
stems
spray
dried
cells
Prior art date
Application number
MX2013014340A
Other languages
English (en)
Spanish (es)
Other versions
MX2013014340A (es
Inventor
Lang Christine
Arya Stefanie
Goelling Detlef
Holz Caterina
Original Assignee
Novozymes As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP11169137A external-priority patent/EP2532354A1/de
Application filed by Novozymes As filed Critical Novozymes As
Publication of MX2013014340A publication Critical patent/MX2013014340A/es
Publication of MX354047B publication Critical patent/MX354047B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Feed For Specific Animals (AREA)
MX2013014340A 2011-06-08 2012-06-08 Cepas/celulas de lactobacillus secadas por aspersion, y el uso de las mismas contra helicobacter pylori. MX354047B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11169137A EP2532354A1 (de) 2011-06-08 2011-06-08 Sprühgetrocknete Lactobacillus Stämme / Zellen und deren Verwendung gegen Helicobacter Pylori
EP11185851 2011-10-19
PCT/EP2012/060948 WO2012168468A1 (de) 2011-06-08 2012-06-08 Sprühgetrocknete lactobacillus stämme / zellen und deren verwendung gegen helicobacter pylori

Publications (2)

Publication Number Publication Date
MX2013014340A MX2013014340A (es) 2014-07-09
MX354047B true MX354047B (es) 2018-02-09

Family

ID=46489179

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013014340A MX354047B (es) 2011-06-08 2012-06-08 Cepas/celulas de lactobacillus secadas por aspersion, y el uso de las mismas contra helicobacter pylori.

Country Status (10)

Country Link
US (1) US20140147427A1 (enExample)
EP (1) EP2717890B1 (enExample)
JP (1) JP6062931B2 (enExample)
CN (1) CN103648511B (enExample)
BR (1) BR112013031325A2 (enExample)
EA (1) EA028340B1 (enExample)
ES (1) ES2600963T3 (enExample)
MX (1) MX354047B (enExample)
PL (1) PL2717890T3 (enExample)
WO (1) WO2012168468A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX370537B (es) * 2013-02-07 2019-12-17 Novozymes As Uso de leche descremada como portador de lactobacillus en la elaboración de una composición para la agregación de helycobacter pylori.
DE202014101285U1 (de) 2014-02-13 2015-03-06 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung zur Behandlung von Magenbeschwerden
US20160143317A1 (en) * 2014-11-24 2016-05-26 Nutrition Physiology Company, Llc Lactic acid bacterium as pet dietary supplement
JP2016150904A (ja) * 2015-02-16 2016-08-22 サントリーホールディングス株式会社 抗腫瘍剤
JP6339526B2 (ja) * 2015-05-22 2018-06-06 アサヒグループホールディングス株式会社 筋肉の分解抑制剤
CN105132329B (zh) * 2015-09-14 2019-04-16 西南民族大学 一种可预防胃溃疡的发酵乳杆菌Lactobacillus fermentum strain Lee及其保健用途
GB2544481B (en) * 2015-11-16 2019-12-11 Century International Enterprises Ltd A wearable article and a method for producing a wearable article
SG11201810492QA (en) * 2016-06-20 2019-01-30 Meiji Co Ltd Upper gastrointestinal flora-improving agent
KR101873899B1 (ko) * 2016-08-09 2018-07-03 씨제이제일제당(주) 락토바실러스 살리바리우스 cjls1511, 상기 균 또는 이의 사균체를 포함하는 동물 사료 첨가제 조성물, 및 상기 사균체의 제조 방법
CN110753553A (zh) * 2017-04-11 2020-02-04 赛瓦图斯有限公司 用于治疗炎症和炎性状况的方法
CN107361232A (zh) * 2017-06-21 2017-11-21 安徽和盛伟业饲料有限公司 一种防治仔鸡冬季腹泻的饲料
CN108403725B (zh) * 2018-05-22 2021-02-09 浙江海正药业股份有限公司 用于治疗消化道溃疡的组合物及其应用
US11617772B2 (en) * 2018-09-11 2023-04-04 Direct Digital Llc Nutritional supplements and therapeutic compositions comprising probiotics
EP3870197A1 (en) 2018-10-24 2021-09-01 Novozymes A/S Probiotic supplement for metabolic health comprising lactobacillus
EP4063474A4 (en) * 2019-11-19 2024-01-24 Inbiolev, S.L. METHOD FOR TREATING MUST AND WINE AND PRODUCT FOR CARRYING OUT THE PROCESS
CN111357841A (zh) * 2020-03-26 2020-07-03 湖南营养树生物科技有限公司 一种抗幽门螺旋杆菌的益生菌白茶的制备方法
CN111548970B (zh) * 2020-05-29 2021-03-26 江南大学 一株能够预防和/或治疗幽门螺杆菌感染的卷曲乳杆菌
CN111471626A (zh) * 2020-05-29 2020-07-31 江南大学 一株能够抑制幽门螺杆菌的瑞士乳杆菌及其应用
CN111632084B (zh) * 2020-06-22 2024-04-26 上海利康精准医疗技术有限公司 一种抑制幽门螺旋杆菌的复合益生菌组合物及其应用
CN112314951A (zh) * 2020-12-04 2021-02-05 王立强 一种可抗幽门螺杆菌的组合物及其制备方法
CN114561313B (zh) * 2021-08-26 2022-09-13 佛山市孛特碧欧微生物科技有限公司 格氏乳杆菌及其应用
CN116004456B (zh) * 2022-12-27 2023-10-27 广西爱生生命科技有限公司 一株抑制幽门螺旋杆菌感染的罗伊氏乳杆菌a21325及其应用
WO2024252019A1 (en) * 2023-06-08 2024-12-12 Dsm Ip Assets B.V. Novel process for producing lactobacillus rhamnosus
GB2634493A (en) * 2023-09-05 2025-04-16 Lant Medical Ltd Veterinary non-antibiotic antimicrobial compositions
WO2025132761A1 (en) 2023-12-22 2025-06-26 Novozymes A/S Producing a lactobacillus strain

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3897307A (en) * 1974-10-23 1975-07-29 Hansens Lab Inc Stabilized dry cultures of lactic acid-producing bacteria
DE3135329A1 (de) 1981-09-05 1983-03-24 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von trockenpulvern oxidationsempfindlicher substanzen
DE3770940D1 (de) 1987-04-06 1991-07-25 Hoffmann La Roche Verfahren zur herstellung von vitaminpraeparaten.
US5716615A (en) * 1992-02-10 1998-02-10 Renata Maria Anna Cavaliere Vesely Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
JP3046303B1 (ja) * 1999-06-24 2000-05-29 明治乳業株式会社 Ｈｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉ除菌性飲食品
JP4509250B2 (ja) * 1999-06-24 2010-07-21 明治乳業株式会社 Ｈｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉ除菌性医薬品
FR2801316B1 (fr) * 1999-11-18 2005-03-25 Rhodia Food Procede de sechage des bacteries
JP3363438B2 (ja) * 2000-05-02 2003-01-08 ビオフェルミン製薬株式会社 噴霧乾燥による菌体乾燥物
EE04580B1 (et) * 2001-06-29 2006-02-15 Tartu �likool Mikroorganismi tüvi Lactobacillus fermentum ME-3 kui antimikroobne ja antioksüdantne probiootikum
US7101565B2 (en) * 2002-02-05 2006-09-05 Corpak Medsystems, Inc. Probiotic/prebiotic composition and delivery method
ES2355890T3 (es) * 2002-04-05 2011-04-01 Societe des Produits Nestlé S.A. Composiciones y métodos para promocionar la asimilación de lípidos en los animales domésticos.
CA2526861A1 (en) 2003-04-02 2004-10-14 Axcan Pharma S.A. Lactobacillus fermentum strain and uses thereof
JP5363811B2 (ja) * 2005-09-28 2013-12-11 ノルディスク リバランス アクティーゼルスカブ 治療エフェクターとしてプロバイオティック細菌と発酵穀物を用いるｉｂｄ及びｉｂｓの治療
DE102005062731A1 (de) * 2005-12-22 2007-06-28 Organobalance Gmbh Neue Lactobacillus Stämme und deren Verwendung
US9084434B2 (en) * 2006-09-27 2015-07-21 Little Calumet Holdings Llc Probiotic oral dosage forms
CN101568638B (zh) * 2006-11-17 2013-01-16 Sca卫生用品公司 发酵乳杆菌Ess-1 DSM17851及其在治疗和/或预防念珠菌病以及尿道感染中的应用
ES2578261T3 (es) * 2007-05-18 2016-07-22 Nestec S.A. Lactobacillus johnsonii para prevenir infecciones postoperatorias
WO2009157073A1 (ja) * 2008-06-26 2009-12-30 信和薬品株式会社 ナノ型乳酸菌

Also Published As

Publication number Publication date
ES2600963T3 (es) 2017-02-13
JP6062931B2 (ja) 2017-01-18
US20140147427A1 (en) 2014-05-29
WO2012168468A1 (de) 2012-12-13
PL2717890T3 (pl) 2017-12-29
BR112013031325A2 (pt) 2017-06-06
EP2717890A1 (de) 2014-04-16
JP2014518897A (ja) 2014-08-07
CN103648511B (zh) 2018-12-07
EA028340B1 (ru) 2017-11-30
EA201391823A1 (ru) 2014-04-30
EP2717890B1 (de) 2016-08-10
MX2013014340A (es) 2014-07-09
CN103648511A (zh) 2014-03-19

Similar Documents

Publication Publication Date Title
MX354047B (es) Cepas/celulas de lactobacillus secadas por aspersion, y el uso de las mismas contra helicobacter pylori.
MX347262B (es) Preparaciones de alimento para mascotas que contienen microorganismos probióticos.
MX386138B (es) Bacteria para usarse como un probiótico para aplicaciones nutricionales y médicas.
WO2012112777A3 (en) Biosynthesis of human milk oligosaccharides in engineered bacteria
MX2017014787A (es) Poblaciones bacterianas para promover la salud.
MX2019009132A (es) Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
MX2011012064A (es) Formula alimenticia para bebes que comprenden microorganismos probioticos.
WO2014018596A3 (en) Alpha (1,2) fucosyltransferases suitable for use in the production of fucosylated oligosaccharides
PH12013500652A1 (en) Frozen confections containing probiotic micro-organisms
PH12013500931A1 (en) Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
IN2012DN01638A (enExample)
NZ706636A (en) Probiotic and prebiotic compositions
PH12017500708A1 (en) Probiotic and prebiotic compositions
HK1207006A1 (en) Daptomycin formulations and uses thereof
PH12013500735A1 (en) Powdered cereal compositions comprising non-replicating probiotic microorganisms
PH12014501369A1 (en) Oral care compositions
PH12013500851A1 (en) Spoonable yogurt preparations containing non-replicating probiotic micro-organisms
PH12013500811A1 (en) Extruded non-replicating probiotic micro-organisms and their health benefits
EP3255140C0 (en) LACTIC ACID BACTERIA, NATURAL IMMUNOACTIVATOR AND INFECTION PREVENTIVE/THERAPEUTIC AGENT DERIVED FROM SAID LACTIC ACID BACTERIA AND FOOD/DRINK
MX2019015306A (es) Probioticos y metodos de uso.
WO2014167582A3 (en) Vaccine composition for prophylaxis in ruminants
MX2017007969A (es) Bacterias de acido lactico y su uso para el tratamiento de mastitis.
IN2012DN01214A (enExample)
WO2012006321A3 (en) Novel antibacterial compounds, methods of making them, and uses thereof
MY170190A (en) Use of a fermented soy extract as a prebiotic composition

Legal Events

Date Code Title Description
GB Transfer or assignment

Owner name: NOVOZYMES A/S

FG Grant or registration